相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies
AnnaLynn M. Williams et al.
LEUKEMIA & LYMPHOMA (2018)
The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation
Nicole Stadler et al.
HAEMATOLOGICA (2017)
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase
Xiao Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages
Lingyan Ping et al.
ONCOTARGET (2017)
Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency
Hoda Mirsafian et al.
SCIENTIFIC REPORTS (2017)
The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation
Nicole Stadler et al.
HAEMATOLOGICA (2017)
The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement
Filomena Monica Cavaliere et al.
PLOS ONE (2017)
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib
Tracy E. Wiczer et al.
BLOOD ADVANCES (2017)
Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression
Martha Garstkiewicz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation
Pranav Murthy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J. Gunderson et al.
CANCER DISCOVERY (2016)
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cells
Gayathri Natarajan et al.
ONCOIMMUNOLOGY (2016)
The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation
Stephanie Volmering et al.
IMMUNITY (2016)
c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor
Ravindra Gujar et al.
JOURNAL OF IMMUNOLOGY (2016)
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation
E. Grassilli et al.
ONCOGENE (2016)
Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes
Li Wei et al.
ONCOTARGET (2016)
A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells
Gayathri Natarajan et al.
ONCOIMMUNOLOGY (2016)
The Inflammasomes and Autoinflammatory Syndromes
Lori Broderick et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer
Leila Kokabee et al.
CANCER BIOLOGY & THERAPY (2015)
Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus
Susanne Herbst et al.
EMBO MOLECULAR MEDICINE (2015)
Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells
Jonathan L. Schmid-Burgk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury
Minako Ito et al.
NATURE COMMUNICATIONS (2015)
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
S. Kamel et al.
LEUKEMIA (2015)
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation
Vassilios Lougaris et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Immunoregulation of Dendritic Cells by the Receptor T cell Ig and Mucin Protein-3 via Bruton's Tyrosine Kinase and c-Src
Neeraj Maurya et al.
JOURNAL OF IMMUNOLOGY (2014)
Bruton's Tyrosine Kinase and Protein Kinase C μ Are Required for TLR7/9-Induced IKKα and IRF-1 Activation and Interferon-β Production in Conventional Dendritic Cells
Yan-Feng Li et al.
PLOS ONE (2014)
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
Cheryl Eifert et al.
GENES CHROMOSOMES & CANCER (2013)
The Tyrosine Kinase Btk Regulates the Macrophage Response to Listeria monocytogenes Infection
Afitap Derya Koepruelue et al.
PLOS ONE (2013)
The B-cell receptor signaling pathway as a therapeutic target in CLL
Jennifer A. Woyach et al.
BLOOD (2012)
Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines
Thomas U. Marron et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Tyrosine Kinase Btk Is Required for NK Cell Activation
Yan Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
Fumiko Honda et al.
NATURE IMMUNOLOGY (2012)
Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
Koon-Guan Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia
Katja Fiedler et al.
BLOOD (2011)
Btk is a positive regulator in the TREM-1/DAP12 signaling pathway
Tereza Ormsby et al.
BLOOD (2011)
A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells
Eshu Singhal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bruton's Tyrosine Kinase Is Required for TLR-Dependent Heme Oxygenase-1 Gene Activation via Nrf2 in Macrophages
Vijith Vijayan et al.
JOURNAL OF IMMUNOLOGY (2011)
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Julie A. Di Paolo et al.
NATURE CHEMICAL BIOLOGY (2011)
TLR signaling and effector functions are intact in XLA neutrophils
Thomas U. Marron et al.
CLINICAL IMMUNOLOGY (2010)
Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia
Hiromichi Taneichi et al.
CLINICAL IMMUNOLOGY (2008)
Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways
Noha Semaan et al.
JOURNAL OF IMMUNOLOGY (2008)
Dual functions of Bruton's tyrosine kinase and tec kinase during Fcγ receptor-induced signaling and phagocytosis
Jenny Jongstra-Bilen et al.
JOURNAL OF IMMUNOLOGY (2008)
Essential roles for the Tec family kinases Tec and Btk in M-CSF receptor signaling pathways that regulate macrophage survival
Martin Melcher et al.
JOURNAL OF IMMUNOLOGY (2008)
Impaired Toll-like receptor 8-mediated IL-6 and TNF-α production in antigen-presenting cells from patients with X-linked agammaglobulinemia
Klara Sochorova et al.
BLOOD (2007)
BDTKbase:: The mutation database for X-linked agammaglobullinemia
Jouni Valiaho et al.
HUMAN MUTATION (2006)
X-linked Agammaglobulinemia - Report on a United States registry of 201 patients
Jerry A. Winkelstein et al.
MEDICINE (2006)
Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment
Yoshinori Nagai et al.
IMMUNITY (2006)
MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction
P Gray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bruton's tyrosine kinase is required for TLR2 and TLR4-Induced TNF, but not IL-6, production
Nicole J. Horwood et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3
Y Kawakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bruton's tyrosine kinase is a toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by toll-like receptor 4
CA Jefferies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
X-chromosome-linked immune-deficient mice have B-1b cells
J Riggs et al.
IMMUNOLOGY (2003)
分享论文
